Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock.

Dong Z, Zhang G, Qu M, Gimple RC, Wu Q, Qiu Z, Prager BC, Wang X, Kim LJY, Morton AR, Dixit D, Zhou W, Huang H, Li B, Zhu Z, Bao S, Mack SC, Chavez L, Kay SA, Rich JN.

Cancer Discov. 2019 Aug 27. pii: CD-19-0215. doi: 10.1158/2159-8290.CD-19-0215. [Epub ahead of print]

PMID:
31455674
2.

Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells.

Wang X, Yang K, Wu Q, Kim LJY, Morton AR, Gimple RC, Prager BC, Shi Y, Zhou W, Bhargava S, Zhu Z, Jiang L, Tao W, Qiu Z, Zhao L, Zhang G, Li X, Agnihotri S, Mischel PS, Mack SC, Bao S, Rich JN.

Sci Transl Med. 2019 Aug 7;11(504). pii: eaau4972. doi: 10.1126/scitranslmed.aau4972.

PMID:
31391321
3.

Mismatch repair-signature mutations activate gene enhancers across human colorectal cancer epigenomes.

Hung S, Saiakhova A, Faber ZJ, Bartels CF, Neu D, Bayles I, Ojo E, Hong ES, Pontius WD, Morton AR, Liu R, Kalady MF, Wald DN, Markowitz S, Scacheri PC.

Elife. 2019 Feb 13;8. pii: e40760. doi: 10.7554/eLife.40760.

4.

Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression.

Wang X, Prager BC, Wu Q, Kim LJY, Gimple RC, Shi Y, Yang K, Morton AR, Zhou W, Zhu Z, Obara EAA, Miller TE, Song A, Lai S, Hubert CG, Jin X, Huang Z, Fang X, Dixit D, Tao W, Zhai K, Chen C, Dong Z, Zhang G, Dombrowski SM, Hamerlik P, Mack SC, Bao S, Rich JN.

Cell Stem Cell. 2018 Apr 5;22(4):514-528.e5. doi: 10.1016/j.stem.2018.03.011.

5.

Composition of human breast milk in acute kidney injury.

Chruscicki A, Morton AR, Akbari A, White CA.

Obstet Med. 2017 Jun;10(2):79-82. doi: 10.1177/1753495X16686276. Epub 2017 Jan 29.

6.

Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.

Miller TE, Liau BB, Wallace LC, Morton AR, Xie Q, Dixit D, Factor DC, Kim LJY, Morrow JJ, Wu Q, Mack SC, Hubert CG, Gillespie SM, Flavahan WA, Hoffmann T, Thummalapalli R, Hemann MT, Paddison PJ, Horbinski CM, Zuber J, Scacheri PC, Bernstein BE, Tesar PJ, Rich JN.

Nature. 2017 Jul 20;547(7663):355-359. doi: 10.1038/nature23000. Epub 2017 Jul 5.

7.

Ramsay Hunt syndrome.

Montague SJ, Morton AR.

CMAJ. 2017 Feb 27;189(8):E320. doi: 10.1503/cmaj.160483. No abstract available.

8.

Sequence variation in vitamin K epoxide reductase gene is associated with survival and progressive coronary calcification in chronic kidney disease.

Holden RM, Booth SL, Tuttle A, James PD, Morton AR, Hopman WM, Nolan RL, Garland JS.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1591-6. doi: 10.1161/ATVBAHA.114.303211. Epub 2014 May 22.

PMID:
24855061
9.

Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3-5 chronic kidney disease patients.

Garland JS, Holden RM, Ross R, Adams MA, Nolan RL, Hopman WM, Morton AR.

J Diabetes Complications. 2014 Jan-Feb;28(1):61-5. doi: 10.1016/j.jdiacomp.2013.09.004. Epub 2013 Oct 11.

PMID:
24125760
10.

Managing hypercalcaemia and hypocalcaemia in cancer patients.

Fallah-Rad N, Morton AR.

Curr Opin Support Palliat Care. 2013 Sep;7(3):265-71. doi: 10.1097/SPC.0b013e3283640f5f. Review.

PMID:
23912385
11.

Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease.

Kerr JD, Holden RM, Morton AR, Nolan RL, Hopman WM, Pruss CM, Garland JS.

BMC Nephrol. 2013 Jan 26;14:26. doi: 10.1186/1471-2369-14-26.

12.

Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients: a Canadian payer perspective.

Vegter S, Tolley K, Keith MS, Lok CE, Soroka SD, Morton AR.

Clin Ther. 2012 Jul;34(7):1531-43. doi: 10.1016/j.clinthera.2012.06.006. Epub 2012 Jun 27.

PMID:
22742885
13.

Fat-soluble vitamins in advanced CKD/ESKD: a review.

Holden RM, Ki V, Morton AR, Clase C.

Semin Dial. 2012 May;25(3):334-43. doi: 10.1111/j.1525-139X.2012.01084.x. Review.

PMID:
22607215
14.

A severe case of iatrogenic lactation ketoacidosis.

Szulewski A, Howes D, Morton AR.

BMJ Case Rep. 2012 Mar 8;2012. pii: bcr1220115409. doi: 10.1136/bcr.12.2011.5409.

15.

Body mass index, coronary artery calcification, and kidney function decline in stage 3 to 5 chronic kidney disease patients.

Garland JS, Holden RM, Hopman WM, Gill SS, Nolan RL, Morton AR.

J Ren Nutr. 2013 Jan;23(1):4-11. doi: 10.1053/j.jrn.2011.12.008. Epub 2012 Apr 28.

PMID:
22542819
16.

DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin.

O'Meara P, Borici-Mazi R, Morton AR, Ellis AK.

Allergy Asthma Clin Immunol. 2011 Oct 3;7:16. doi: 10.1186/1710-1492-7-16.

17.

Australian association for exercise and sports science position statement on exercise and asthma.

Morton AR, Fitch KD.

J Sci Med Sport. 2011 Jul;14(4):312-6. doi: 10.1016/j.jsams.2011.02.009. Epub 2011 Mar 26. Review.

PMID:
21440499
18.

Is the calcium correct? Measuring serum calcium in dialysis patients.

Morton AR, Garland JS, Holden RM.

Semin Dial. 2010 May-Jun;23(3):283-9. doi: 10.1111/j.1525-139X.2010.00735.x. Epub 2010 May 10. Review.

PMID:
20492582
19.

Development and utility of a multi-dimensional grid to assess individual mineral metabolism control in hemodialysis patients: A potential aid for therapeutic decision making?

Morton AR, Murphy S, Hirsch D, Leblanc M, Barré P, Lok C, Hercz G, Hodsman A, Reslerova M, Levin A.

Hemodial Int. 2010 Apr;14(2):200-10. doi: 10.1111/j.1542-4758.2009.00426.x. Epub 2010 Mar 12.

PMID:
20337745
20.

Vitamins K and D status in stages 3-5 chronic kidney disease.

Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL.

Clin J Am Soc Nephrol. 2010 Apr;5(4):590-7. doi: 10.2215/CJN.06420909. Epub 2010 Feb 18.

21.

Spontaneous peritoneal membrane rupture with extravasation of peritoneal fluid into the lower limbs and flank in a peritoneal dialysis patient.

Benaroia M, Morton AR, Cheeseman FD, Garland JS, Toffelmire EB.

Perit Dial Int. 2008 Sep-Oct;28(5):554-7. No abstract available.

PMID:
18708555
22.

Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease.

Garland JS, Holden RM, Groome PA, Lam M, Nolan RL, Morton AR, Pickett W.

Am J Kidney Dis. 2008 Nov;52(5):849-58. doi: 10.1053/j.ajkd.2008.04.012. Epub 2008 Jun 17.

PMID:
18562059
23.

Vitamin K status of Canadian peritoneal dialysis patients.

Holden RM, Iliescu E, Morton AR, Booth SL.

Perit Dial Int. 2008 Jul-Aug;28(4):415-8. No abstract available.

PMID:
18556387
24.

Statins are associated with a reduced risk of bone fracture in hemodialysis (HD) patients.

Nichols R, Hopman WM, Morton AR, Harman GJ, Holden RM.

Hemodial Int. 2008 Apr;12(2):275-9. doi: 10.1111/j.1542-4758.2008.00265.x.

PMID:
18394063
25.

Warfarin and aortic valve calcification in hemodialysis patients.

Holden RM, Sanfilippo AS, Hopman WM, Zimmerman D, Garland JS, Morton AR.

J Nephrol. 2007 Jul-Aug;20(4):417-22.

PMID:
17879207
26.

Subclinical vitamin K deficiency in hemodialysis patients.

Pilkey RM, Morton AR, Boffa MB, Noordhof C, Day AG, Su Y, Miller LM, Koschinsky ML, Booth SL.

Am J Kidney Dis. 2007 Mar;49(3):432-9.

PMID:
17336705
27.

The problem with Kt/V: dialysis dose should be normalized to metabolic rate not volume.

Morton AR, Singer MA.

Semin Dial. 2007 Jan-Feb;20(1):12-5. Review.

PMID:
17244112
28.

Monitoring 6 weeks of progressive endurance training with plasma glutamine.

Kargotich S, Keast D, Goodman C, Bhagat CI, Joske DJ, Dawson B, Morton AR.

Int J Sports Med. 2007 Mar;28(3):211-6. Epub 2006 Oct 6.

PMID:
17024635
29.

Adequacy of glycemic control in hemodialysis patients with diabetes.

Tascona DJ, Morton AR, Toffelmire EB, Holland DC, Iliescu EA.

Diabetes Care. 2006 Oct;29(10):2247-51.

PMID:
17003301
30.

Modality choice among Aboriginal incident dialysis patients--influence of geographic location.

Iliescu EA, Yeates KE, McComb J, Morton AR.

Perit Dial Int. 2006 Jul-Aug;26(4):507-8. No abstract available.

PMID:
16881349
31.

Vasopressin antagonists: role in the management of hyponatremia.

Yeates KE, Morton AR.

Am J Nephrol. 2006;26(4):348-55. Epub 2006 Jul 11. Review.

32.

Sevelamer hydrochloride in peritoneal dialysis patients: ca' canny but ca' awa'.

Garland JS, Morton AR.

Perit Dial Int. 2006 May-Jun;26(3):300-5. No abstract available.

PMID:
16722019
33.

Plasma glutamine responses to high-intensity exercise before and after endurance training.

Kargotich S, Goodman C, Dawson B, Morton AR, Keast D, Joske DJ.

Res Sports Med. 2005 Oct-Dec;13(4):287-300.

PMID:
16440504
34.

Reliability of physiological, psychological, and cognitive variables in chronic fatigue syndrome.

Wallman KE, Morton AR, Goodman C, Grove R.

Res Sports Med. 2005 Jul-Sep;13(3):231-41.

PMID:
16392538
35.

Plasma glutamine changes after high-intensity exercise in elite male swimmers.

Kargotich S, Rowbottom DG, Keast D, Goodman C, Dawson B, Morton AR.

Res Sports Med. 2005 Jan-Mar;13(1):7-21.

PMID:
16389883
36.

Reliability of physiological, psychological and cognitive variables in chronic fatigue syndrome and the role of graded exercise.

Wallman KE, Morton AR, Goodman C, Grove R.

J Sports Sci Med. 2005 Dec 1;4(4):463-71. eCollection 2005 Dec.

37.

Exercise prescription for individuals with chronic fatigue syndrome.

Wallman KE, Morton AR, Goodman C, Grove R.

Med J Aust. 2005 Aug 1;183(3):142-3. Review. No abstract available.

PMID:
16053417
38.

25-hydroxyvitamin D in peritoneal dialysis patients: a substrate for investigation.

Morton AR.

Perit Dial Int. 2005 Jul-Aug;25(4):343-7. Review. No abstract available.

PMID:
16022089
39.

Physiological responses during a submaximal cycle test in chronic fatigue syndrome.

Wallman KE, Morton AR, Goodman C, Grove R.

Med Sci Sports Exerc. 2004 Oct;36(10):1682-8.

PMID:
15595287
40.

Independent and additive effects of energy restriction and exercise on glucose and insulin concentrations in sedentary overweight men.

Cox KL, Burke V, Morton AR, Beilin LJ, Puddey IB.

Am J Clin Nutr. 2004 Aug;80(2):308-16.

PMID:
15277150
41.

Randomised controlled trial of graded exercise in chronic fatigue syndrome.

Wallman KE, Morton AR, Goodman C, Grove R, Guilfoyle AM.

Med J Aust. 2004 May 3;180(9):444-8.

PMID:
15115421
42.

Salt and water: a simple approach to hyponatremia.

Yeates KE, Singer M, Morton AR.

CMAJ. 2004 Feb 3;170(3):365-9. Review. Erratum in: CMAJ. 2004 Mar 16;170(6):931.

43.

Exercise improves early functional recovery after total hip arthroplasty.

Gilbey HJ, Ackland TR, Wang AW, Morton AR, Trouchet T, Tapper J.

Clin Orthop Relat Res. 2003 Mar;(408):193-200.

PMID:
12616059
45.

A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.

Wolfson M, Piraino B, Hamburger RJ, Morton AR; Icodextrin Study Group.

Am J Kidney Dis. 2002 Nov;40(5):1055-65.

PMID:
12407652
46.

Apolipoprotein(a) phenotype and lipoprotein(a) level predict peritoneal dialysis patient mortality.

Iliescu EA, Marcovina SM, Morton AR, Lam M, Koschinsky ML.

Perit Dial Int. 2002 Jul-Aug;22(4):492-9.

PMID:
12322821
47.

Quantification of terbutaline in urine by enzyme-linked immunosorbent assay and capillary electrophoresis after oral and inhaled administrations.

Roig M, Bergés R, Ventura R, Fitch KD, Morton AR, Segura J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Mar 5;768(2):315-24.

PMID:
11888060
48.

Loss of the right to administer general anaesthesia.

Morton AR.

SAAD Dig. 1999 Jul;16(3):30-1. No abstract available.

PMID:
11833138
49.

Nephrology: 1. Investigation and treatment of recurrent kidney stones.

Morton AR, Iliescu EA, Wilson JW.

CMAJ. 2002 Jan 22;166(2):213-8. Review. No abstract available.

50.

Nephrology in practice: a new series.

Morton AR, Wooltorton E.

CMAJ. 2002 Jan 22;166(2):195. No abstract available.

Supplemental Content

Loading ...
Support Center